VSVittoria Schirinzi

Vittoria Schirinzi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vittoria Schirinzi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Alessandro Leone

    Division of Human Nutrition, Department of Food, Environmental and Nutritional Sciences (DeFENS), Università degli Studi di Milano, Milano, Italy

    1 shared publication
  • Carolina Poli

    Professional Development and Implementation of Research in Health Professions Unit, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40126 Bologna, Italy

    1 shared publication
  • Chiara Berteotti

    PRISM Lab, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy

    1 shared publication
  • Francesca Menichetti

    International Center for the Assessment of Nutritional Status and the Development of Dietary Intervention Strategies (ICANS-DIS), Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, 20133 Milan, Italy

    1 shared publication
  • Roberta Arrighi

    International Center for the Assessment of Nutritional Status and the Development of Dietary Intervention Strategies (ICANS-DIS), Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, 20133 Milan, Italy

    1 shared publication

Latest Publications

  • Open Access

    Moringa oleifera and Blood Pressure: Evidence and Potential Mechanisms

    by Francesca Menichetti, Chiara Berteotti, Vittoria Schirinzi, Carolina Poli, Roberta Arrighi, Alessandro Leone

    The prevalence of hypertension is increasing worldwide, in particular in developing countries. Anti-hypertensive drugs are commonly used to treat hypertension. However, in developing countries, where access to health care is scarce and the supply system is poor, anti-hypertensive drugs may not always be available. Moringa oleifera is a plant widely found in developing countries, with its leaves, seeds, flowers, roots, and pods used both for nutritional purposes and in traditional medicine to treat various diseases, including hypertension. This review summarizes the evidence, both in animal and human models, about the antihypertensive effects of different parts of M. oleifera, discusses possible mechanisms of action, explores its bioactive compounds with potential antihypertensive properties, and highlights the limitations of its use as a hypotensive agent. Many preclinical studies attribute antihypertensive properties to M. oleifera, particularly the leaves. However, it is premature to draw firm conclusions, as there is a great lack of randomized controlled trials demonstrating its real efficacy. The mechanisms of action and the compounds responsible for the hypotensive effect have not yet been fully elucidated. Therefore, further clinical trials showing its efficacy are strongly required before promoting Moringa for therapeutic purposes. At present, Moringa remains a plant with nutritional and pharmacological potential.